Génmódosított anti-TGF-béta ellenanyagok és antigénkötõ fragmensek

• 收藏
• 分享

专利权人:

Genzyme Corporation

发明人:

WEI, Ronnie,MOULIN, Aaron,MATHIEU, Magali,PAN, Clark,PARK, Sunghae,QIU, Huawei

申请号：

HUE14779440

公开号：

HUE042020T2

申请日:

2014.03.11

申请国别(地区):

HU

年份:

2019

代理人:

摘要：

Antibodies or antigen-binding fragments thereof are engineered to bind Transforming Growth Factor-² (TGF²). TGF²-isoform selective antibodies or antigen-binding fragments thereof may selectively bind human TGF²1 compared to human TGF²2 and human TGF²3, or may selectively bind human TGF²3, compared to human TGF²1 and human TGF²2. The design of the antibodies or antigen-binding fragments thereof is facilitated by a co-crystal structure of a recombinant Fab fragment of GC1008 bound to TGF²2 and by another co-crystal structure of the scFv version of GC1008 bound to TGF²1.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/